DOES ANTIRHEUMATIC THERAPY INFLUENCE THE DEVELOPMENT OF SECONDARY AMYLOIDOSIS IN RHEUMATOID-ARTHRITIS

Authors
PROKAEVA TB ALEKBEROVA ZS RODENSKALOPOVOK SG TIITINEN S KAARELA K KAUTIAINEN H
Citation
Tb. Prokaeva et al., DOES ANTIRHEUMATIC THERAPY INFLUENCE THE DEVELOPMENT OF SECONDARY AMYLOIDOSIS IN RHEUMATOID-ARTHRITIS, Terapevticeskij arhiv, 67(5), 1995, pp. 47-49
Citations number
NO
Categorie Soggetti
Medicine, General & Internal
Journal title
Terapevticeskij arhiv → ACNP
ISSN journal
00403660
Volume
67
Issue
5
Year of publication
1995
Pages
47 - 49
Database
ISI
SICI code
0040-3660(1995)67:5<47:DATITD>2.0.ZU;2-L
Abstract
Anti-rheumatic drug treatments were studied in 260 patients from Finla nd and Russia suffeiring from rheumatoid arthritis (RA) with or withou t biopsy-proven secondary amyloidosis (RSA). Chloroquine was used for longer period in RSA group in Russia (p = 0.003) and in Finland (p = 0 .06). In Finland chloroquine was used more often in tile RSA group (p = 0. 02), and sulphasalazine (p = 0.02), D-penicillamine (p = 0.03) an d cytotoxics (p = 0.04) in the control group. The role of therapy in t he prevention of RSA in chronic inflammation is discussed.